Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Aquestive Therapeutics Inc (AQST)

Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Aquestive Therapeutics: Q1 Earnings Snapshot

Aquestive Therapeutics: Q1 Earnings Snapshot

AQST : 2.42 (-1.22%)
Aquestive Therapeutics: Q4 Earnings Snapshot

Aquestive Therapeutics: Q4 Earnings Snapshot

AQST : 2.42 (-1.22%)
Aquestive Therapeutics: Q3 Earnings Snapshot

Aquestive Therapeutics: Q3 Earnings Snapshot

AQST : 2.42 (-1.22%)
Aquestive Therapeutics: Q2 Earnings Snapshot

Aquestive Therapeutics: Q2 Earnings Snapshot

AQST : 2.42 (-1.22%)
Aquestive Therapeutics: Q1 Earnings Snapshot

Aquestive Therapeutics: Q1 Earnings Snapshot

AQST : 2.42 (-1.22%)
Aquestive Therapeutics: Q4 Earnings Snapshot

Aquestive Therapeutics: Q4 Earnings Snapshot

AQST : 2.42 (-1.22%)
Aquestive Therapeutics: Q3 Earnings Snapshot

Aquestive Therapeutics: Q3 Earnings Snapshot

AQST : 2.42 (-1.22%)
Aquestive Therapeutics Strengthens Team to Align with Strategic Focus on Allergy Space

Appoints Timothy E. Morris, a veteran biotech executive with over 35 years of experience in executive and financial leadership, to Board of DirectorsNames...

AQST : 2.42 (-1.22%)
Aquestive Therapeutics, Inc. (AQST) Q2 2022 Earnings Call Transcript

AQST earnings call for the period ending June 30, 2022.

AQST : 2.42 (-1.22%)
Aquestive Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update

Completed EPIPHAST trial successfully demonstrating rapid and significant epinephrine exposure under a variety of real-world conditions after...

AQST : 2.42 (-1.22%)

Barchart Exclusives

Is This Copper Mining Stock a Buy for Its Fat Dividend?
Southern Copper has a higher dividend yield compared to other copper mining companies. However, its valuations are also on the higher side, making a closer examination of the risk-reward necessary for prospective investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar